IL101622A - Pharmaceutical preparations containing fibrous calcitonin - Google Patents

Pharmaceutical preparations containing fibrous calcitonin

Info

Publication number
IL101622A
IL101622A IL10162292A IL10162292A IL101622A IL 101622 A IL101622 A IL 101622A IL 10162292 A IL10162292 A IL 10162292A IL 10162292 A IL10162292 A IL 10162292A IL 101622 A IL101622 A IL 101622A
Authority
IL
Israel
Prior art keywords
calcitonin
fibrillated
fibrils
hct
fragmented
Prior art date
Application number
IL10162292A
Other languages
English (en)
Hebrew (he)
Other versions
IL101622A0 (en
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of IL101622A0 publication Critical patent/IL101622A0/xx
Publication of IL101622A publication Critical patent/IL101622A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
IL10162292A 1991-04-23 1992-04-16 Pharmaceutical preparations containing fibrous calcitonin IL101622A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919108634A GB9108634D0 (en) 1991-04-23 1991-04-23 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
IL101622A0 IL101622A0 (en) 1992-12-30
IL101622A true IL101622A (en) 1996-06-18

Family

ID=10693744

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10162292A IL101622A (en) 1991-04-23 1992-04-16 Pharmaceutical preparations containing fibrous calcitonin

Country Status (19)

Country Link
US (1) US5593962A (de)
EP (1) EP0510913B1 (de)
JP (1) JP3532580B2 (de)
KR (1) KR100245534B1 (de)
AT (1) ATE194775T1 (de)
AU (1) AU653395B2 (de)
CA (1) CA2066532C (de)
CY (1) CY2246B1 (de)
DE (1) DE69231263T2 (de)
DK (1) DK0510913T3 (de)
ES (1) ES2150418T3 (de)
GB (1) GB9108634D0 (de)
GR (1) GR3034414T3 (de)
IE (1) IE921278A1 (de)
IL (1) IL101622A (de)
MX (1) MX9201825A (de)
NZ (1) NZ242440A (de)
PT (1) PT510913E (de)
ZA (1) ZA922899B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5595760A (en) * 1994-09-02 1997-01-21 Delab Sustained release of peptides from pharmaceutical compositions
EP1161257A2 (de) 1999-03-17 2001-12-12 Novartis AG Tgf-beta enthaltende pharmazeutische zusammensetzungen
EP1251867A4 (de) 2000-02-04 2004-12-08 Unigene Lab Inc Nasale calcitoninformulierungen
ME00509B (de) 2002-09-27 2011-10-10 Zentaris Gmbh Darreichungsform für pharmazeutisch aktive peptide mit anhaltender wirkstofffreigabe (sustained release) und verfahren zu deren herstellung
GB0422644D0 (en) * 2004-10-12 2004-11-10 Novartis Ag Organic compounds
GB0511269D0 (en) 2005-06-02 2005-07-13 Creative Peptides Sweden Ab Sustained release preparation of pro-insulin C-peptide
EP2282763B1 (de) * 2008-04-07 2013-12-11 National Institute Of Immunology Verfahren zur Herstellung supramolelularer Calcitoninaggregate

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61267528A (ja) * 1984-11-26 1986-11-27 Yamanouchi Pharmaceut Co Ltd 吸収促進剤を含有するカルシトニン経鼻剤
MY102411A (en) * 1986-12-23 1992-06-17 Ciba Geigy Ag Nasal solutions

Also Published As

Publication number Publication date
GB9108634D0 (en) 1991-06-12
ATE194775T1 (de) 2000-08-15
PT510913E (pt) 2000-12-29
AU653395B2 (en) 1994-09-29
EP0510913B1 (de) 2000-07-19
CA2066532A1 (en) 1992-10-24
IE921278A1 (en) 1992-11-04
MX9201825A (es) 1992-10-01
NZ242440A (en) 1993-10-26
DE69231263T2 (de) 2000-12-21
EP0510913A3 (en) 1993-12-15
CY2246B1 (en) 2003-07-04
JP3532580B2 (ja) 2004-05-31
KR100245534B1 (ko) 2000-03-02
AU1506692A (en) 1992-10-29
GR3034414T3 (en) 2000-12-29
DK0510913T3 (da) 2000-10-16
IL101622A0 (en) 1992-12-30
ZA922899B (en) 1993-10-22
ES2150418T3 (es) 2000-12-01
JPH05139993A (ja) 1993-06-08
EP0510913A2 (de) 1992-10-28
DE69231263D1 (de) 2000-08-24
CA2066532C (en) 2003-08-19
US5593962A (en) 1997-01-14

Similar Documents

Publication Publication Date Title
EP1417972B2 (de) Teriparatidhaltige stabilisierte Lösungen
US7144861B2 (en) Stabilized teriparatide solutions
JP2828250B2 (ja) 真性糖尿病の治療
JP3065662B2 (ja) 副甲状腺ホルモン製剤
US5374620A (en) Growth-promoting composition and its use
RU2463040C2 (ru) Композиция и микросфера с контролируемым высвобождением экзендина и способ получения микросферы
US5681814A (en) Formulated IGF-I Composition
JP2003525846A (ja) ヒトインスリン誘導体の集合体
JP2000504696A (ja) 安定化された成長ホルモン処方物およびその製造方法
JPH10507182A (ja) 成長ホルモンおよびイソロイシンを含んでなる医薬製剤
JPH10507181A (ja) 成長ホルモンおよびバリンを含んでなる医薬製剤
US8871713B2 (en) Formulations of growth hormone releasing factor (GRF) molecules with improved stability
EP0510913B1 (de) Calcitonin enthaltende pharmazeutische Zusammensetzungen
JPH08505617A (ja) インシュリン状成長因子を含有する安定溶液
US6767892B1 (en) Compositions providing for increased IGF-I solubility
IE83304B1 (en) Pharmaceutical compositions comprising calcitonin
JP2002510653A (ja) 緩衝剤としてコハク酸を含有する注射可能なｉｇｆ処方物
JP2007161702A (ja) 水性吸入用医薬組成物
KR20230079305A (ko) 인슐린을 포함하는 초 장시간 지속형 약학 조성물
JPH10507183A (ja) 成長ホルモンおよびロイシンを含んでなる医薬製剤
JP2001522814A (ja) 増大されたｉｇｆ−ｉ溶解性を提供する組成物
JPH0565231A (ja) エリスロポエチンの持続性製剤
AU2003213511A1 (en) Stabilized Teriparatide Solutions
HK1021798B (en) Stabilized teriparatide solutions
WO1998005358A1 (fr) Preparations pour injection a liberation prolongee, contenant du gabexate-mesylate

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed